BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24268127)

  • 1. Impact of parathyroidectomy on cardiovascular outcomes and survival in chronic hemodialysis patients with secondary hyperparathyroidism. A retrospective study of 50 cases prior to the calcimimetics era.
    Conzo G; Perna AF; Savica V; Palazzo A; Della Pietra C; Ingrosso D; Satta E; Capasso G; Santini L; Docimo G
    BMC Surg; 2013; 13 Suppl 2(Suppl 2):S4. PubMed ID: 24268127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of parathyroidectomy versus calcimimetics for secondary hyperparathyroidism and kidney transplantation: a propensity-matched analysis.
    Koh EY; van der Plas WY; Dulfer RR; Pol RA; Kruijff S; Rotmans JI; Appelman-Dijkstra N; Schepers A; de Borst MH; Hoorn EJ; van Ginhoven TM; Nieveen van Dijkum EJM; Vogt L; Engelsman AF;
    Langenbecks Arch Surg; 2020 Sep; 405(6):851-859. PubMed ID: 32778916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low parathyroid hormone levels after parathyroidectomy reduce cardiovascular mortality in chronic hemodialysis patients.
    Iwamoto N; Sato N; Nishida M; Hashimoto T; Kobayashi H; Yamazaki S; Okino K; Nishimura M; Takatani T; Okamoto Y; Nakanouchi T; Koyama M; Adachi N; Ninomiya K; Mabuchi H; Iseki K
    Clin Exp Nephrol; 2016 Oct; 20(5):808-814. PubMed ID: 26677857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
    Parfrey PS; Drüeke TB; Block GA; Correa-Rotter R; Floege J; Herzog CA; London GM; Mahaffey KW; Moe SM; Wheeler DC; Kubo Y; Dehmel B; Goodman WG; Chertow GM;
    Clin J Am Soc Nephrol; 2015 May; 10(5):791-9. PubMed ID: 25710802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism.
    Moldovan D; Racasan S; Kacso IM; Rusu C; Potra A; Bondor C; Patiu IM; Gherman-Căprioară M
    Int Urol Nephrol; 2015 Nov; 47(11):1871-7. PubMed ID: 26377492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the Introduction of Calcimimetics on Timing of Parathyroidectomy in Secondary and Tertiary Hyperparathyroidism.
    van der Plas WY; Engelsman AF; Özyilmaz A; van der Horst-Schrivers AN; Meijer K; van Dam GM; Pol RA; de Borst MH; Kruijff S
    Ann Surg Oncol; 2017 Jan; 24(1):15-22. PubMed ID: 27459979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism.
    Costa-Hong V; Jorgetti V; Gowdak LH; Moyses RM; Krieger EM; De Lima JJ
    Surgery; 2007 Nov; 142(5):699-703. PubMed ID: 17981190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term function of parathyroid subcutaneous autoimplantation after presumed total parathyroidectomy in the treatment of secondary hyperparathyroidism. A clinical retrospective study.
    Conzo G; Della Pietra C; Tartaglia E; Gambardella C; Mauriello C; Palazzo A; Santini L; Fei L; Rossetti G; Docimo G; Perna A
    Int J Surg; 2014; 12 Suppl 1():S165-9. PubMed ID: 24866066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total parathyroidectomy improves survival of hemodialysis patients with secondary hyperparathyroidism.
    Iwamoto N; Sato N; Nishida M; Hashimoto T; Kobayashi H; Yamasaki S; Ono T; Nishimura M; Tokoro T; Sakoda C; Murakawa M; Okino K; Okamoto Y; Imai R; Adachi N; Ninomiya K; Mabuchi H; Koyama M; Nakanouchi T; Iseki K
    J Nephrol; 2012; 25(5):755-63. PubMed ID: 22135031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroidectomy improves cardiovascular outcome in nondiabetic dialysis patients with secondary hyperparathyroidism.
    Lin HC; Chen CL; Lin HS; Chou KJ; Fang HC; Liu SI; Hsu CY; Huang WC; Huang CW; Huang CK; Chang TY; Chang YT; Lee PT
    Clin Endocrinol (Oxf); 2014 Apr; 80(4):508-15. PubMed ID: 24102421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroidectomy in the Management of Secondary Hyperparathyroidism.
    Lau WL; Obi Y; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2018 Jun; 13(6):952-961. PubMed ID: 29523679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evolution of the incidence and results at 12 months of parathyroidectomy: 40 years of experience in a dialysis center with two successive surgical departments].
    Jean G; Lifante JC; Bresson É; Ramackers JM; Chazot G; Chazot C
    Nephrol Ther; 2022 Dec; 18(7):616-626. PubMed ID: 36328900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of parathyroidectomy in renal hyperparathyroidism in patients with No access to renal transplantation in Singapore.
    Rajeev P; Lee KY; Tang XJ; Goo TT; Tan WB; Ngiam KY
    Int J Surg; 2016 Jan; 25():64-8. PubMed ID: 26612524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current therapeutic options for the treatment of secondary hyperparathyroidism in end-stage renal disease patients treated with hemodialysis: a 12-month comparative study.
    Dudar I; Shifris I; Dudar S; Kulish V
    Pol Merkur Lekarski; 2022 Oct; 50(299):294-298. PubMed ID: 36283011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of calcimimetics in surgery of secondary hyperparathyroidism.
    Ruiz J; Ríos A; Rodríguez JM; Llorente S; Hernández AM; Parrilla P
    Endocrinol Diabetes Nutr; 2017 Jan; 64(1):59-61. PubMed ID: 28440773
    [No Abstract]   [Full Text] [Related]  

  • 16. Calcimimetics versus parathyroidectomy: What is preferable?
    Rroji M; Spasovski G
    Int Urol Nephrol; 2018 Jul; 50(7):1271-1275. PubMed ID: 29532306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroidectomy and survival in a cohort of Italian dialysis patients: results of a multicenter, observational, prospective study.
    Tartaglione L; Rotondi S; Aucella F; Bonomini M; Caruso MR; Casino F; Cuzziol C; Farcomeni A; Filippini A; Lomonte C; Marinelli R; Rolla D; Rubino F; Seminara G; Pasquali M; Mazzaferro S;
    J Nephrol; 2023 Sep; 36(7):1947-1955. PubMed ID: 37351832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroidectomy Versus Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients.
    Alvarado L; Sharma N; Lerma R; Dwivedi A; Ahmad A; Hechanova A; Payan-Schober F; Nwosu A; Alkhalili E
    World J Surg; 2022 Apr; 46(4):813-819. PubMed ID: 35022799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy analysis of medical and surgical treatments in chronic kidney disease patients with secondary hyperparathyroidism.
    Huang Y; Wu H; Wu Y; Luo Z
    Am J Otolaryngol; 2019; 40(6):102228. PubMed ID: 31375304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term mortality after parathyroidectomy among chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis.
    Chen L; Wang K; Yu S; Lai L; Zhang X; Yuan J; Duan W
    Ren Fail; 2016 Aug; 38(7):1050-8. PubMed ID: 27198474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.